B. Bielekova, M. Sung, N. Kadom, R. Simon, H. Mcfarland et al., Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis, The Journal of Immunology, vol.172, issue.6, pp.3893-904, 2004.
DOI : 10.4049/jimmunol.172.6.3893

B. Bielekova, A. Lincoln, H. Mcfarland, and R. Martin, Therapeutic Potential of Phosphodiesterase-4 and -3 Inhibitors in Th1-Mediated Autoimmune Diseases, The Journal of Immunology, vol.164, issue.2, pp.1117-1141, 2000.
DOI : 10.4049/jimmunol.164.2.1117

H. Batoulis, K. Addicks, and S. Kuerten, Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm, Annals of Anatomy - Anatomischer Anzeiger, vol.192, issue.4, pp.179-93, 2010.
DOI : 10.1016/j.aanat.2010.06.006

I. Stromnes, L. Cerretti, D. Liggitt, R. Harris, and J. Goverman, Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells, Nature Medicine, vol.192, issue.3, pp.337-379, 2008.
DOI : 10.1038/nm1715

E. Frohman, M. Racke, and C. Raine, Multiple Sclerosis ??? The Plaque and Its Pathogenesis, New England Journal of Medicine, vol.354, issue.9, pp.942-55, 2006.
DOI : 10.1056/NEJMra052130

M. Sospedra and R. Martin, IMMUNOLOGY OF MULTIPLE SCLEROSIS, Annual Review of Immunology, vol.23, issue.1, pp.683-747, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115707

C. Rudd, A. Taylor, and H. Schneider, CD28 and CTLA-4 coreceptor expression and signal transduction, Immunological Reviews, vol.11, issue.Suppl. 4, pp.12-26, 2009.
DOI : 10.1111/j.1600-065X.2009.00770.x

P. Perrin, D. Scott, L. Quigley, P. Albert, O. Feder et al., Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis, J Immunol, vol.154, pp.1481-90, 1995.

M. Racke, D. Scott, L. Quigley, G. Gray, R. Abe et al., Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis., Journal of Clinical Investigation, vol.96, issue.5, pp.2195-203, 1995.
DOI : 10.1172/JCI118274

A. Windhagen, J. Newcombe, F. Dangond, C. Strand, M. Woodroofe et al., Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions, Journal of Experimental Medicine, vol.182, issue.6, pp.1985-96, 1995.
DOI : 10.1084/jem.182.6.1985

B. Marinari, A. Costanzo, V. Marzano, E. Piccolella, and L. Tuosto, CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-??B subunits on IL-8 and Bcl-xL gene promoters, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6098-103, 2004.
DOI : 10.1073/pnas.0308688101

L. Tuosto, NF-??B family of transcription factors: Biochemical players of CD28 co-stimulation, Immunology Letters, vol.135, issue.1-2, pp.1-9, 2011.
DOI : 10.1016/j.imlet.2010.09.005

S. Saccani, S. Pantano, and G. Natoli, Two Waves of Nuclear Factor ??b Recruitment to Target Promoters, The Journal of Experimental Medicine, vol.16, issue.12, pp.1351-60, 2001.
DOI : 10.1093/emboj/17.5.1454

E. Acosta-rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto, Interleukins 1?? and 6 but not transforming growth factor-?? are essential for the differentiation of interleukin 17???producing human T helper cells, Nature Immunology, vol.161, issue.9, pp.942-951, 2007.
DOI : 10.1084/jem.191.10.1777

N. Manel, D. Unutmaz, and D. Littman, The differentiation of human TH-17 cells requires transforming growth factor-?? and induction of the nuclear receptor ROR??t, Nature Immunology, vol.171, issue.6, pp.641-650, 2008.
DOI : 10.1084/jem.189.11.1735

E. Volpe, N. Servant, R. Zollinger, S. Bogiatzi, P. Hupe et al., A critical function for transforming growth factor-??, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses, Nature Immunology, vol.174, issue.6, pp.650-657, 2008.
DOI : 10.1084/jem.20012076

L. Yang, D. Anderson, C. Baecher-allan, W. Hastings, E. Bettelli et al., IL-21 and TGF-?? are required for differentiation of human TH17 cells, Nature, vol.282, issue.7202, pp.350-352, 2008.
DOI : 10.1038/nature07021

L. Zhou, I. Ivanov, R. Spolski, R. Min, K. Shenderov et al., IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nature Immunology, vol.178, issue.9, pp.967-74, 2007.
DOI : 10.1128/MCB.24.6.2385-2396.2004

W. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.121-128, 2001.
DOI : 10.1002/ana.1032

F. Lublin and S. Reingold, Defining the clinical course of multiple sclerosis: Results of an international survey, Neurology, vol.46, issue.4, pp.907-918, 1996.
DOI : 10.1212/WNL.46.4.907

A. Civil, I. Rensink, L. Aarden, and C. Verwei, Functional Disparity of Distinct CD28 Response Elements toward Mitogenic Responses, Journal of Biological Chemistry, vol.274, issue.48, pp.34369-74, 1999.
DOI : 10.1074/jbc.274.48.34369

F. Ouaaz, M. Li, and A. Beg, A Critical Role for the RelA Subunit of Nuclear Factor ??B in Regulation of Multiple Immune-response Genes and in Fas-induced Cell Death, The Journal of Experimental Medicine, vol.159, issue.6, pp.999-1004, 1999.
DOI : 10.1016/S0092-8674(00)80174-9

E. Acosta-rodriguez, L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno et al., Surface phenotype and antigenic specificity of human interleukin 17???producing T helper memory cells, Nature Immunology, vol.179, issue.6, pp.639-685, 2007.
DOI : 10.1038/ni1467

F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta et al., Phenotypic and functional features of human Th17 cells, The Journal of Experimental Medicine, vol.162, issue.8, pp.1849-61, 2007.
DOI : 10.1634/stemcells.2005-0008

A. Reboldi, C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli et al., C-C chemokine receptor 6???regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nature Immunology, vol.181, issue.5, pp.514-537, 2009.
DOI : 10.1002/glia.1101

M. Pinto-medel, J. Garcia-leon, B. Oliver-martos, C. Lopez-gomez, G. Luque et al., The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis, Journal of Neuroimmunology, vol.243, issue.1-2, pp.1-11, 2012.
DOI : 10.1016/j.jneuroim.2011.11.008

F. Jadidi-niaragh and A. Mirshafiey, Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis, Scandinavian Journal of Immunology, vol.207, issue.Suppl 5, pp.1-13, 2011.
DOI : 10.1111/j.1365-3083.2011.02536.x

W. Jin, X. Zhou, Y. J. Cheng, X. Sun, and S. , Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK, Blood, vol.113, issue.26, pp.6603-6613, 2009.
DOI : 10.1182/blood-2008-12-192914

L. Li, Q. Ruan, B. Hilliard, J. Devirgiliis, K. M. Chen et al., Transcriptional regulation of the Th17 immune response by IKK??, The Journal of Experimental Medicine, vol.208, issue.4, pp.787-96, 2011.
DOI : 10.1016/j.immuni.2007.11.016

M. Muscolini, A. Sajeva, S. Caristi, and L. Tuosto, A novel association between filamin A and NF-kappaB inducing kinase couples CD28 to inhibitor of NF-kappaB kinase alpha and NF-kappaB activation, Immunol Lett, vol.36, pp.203-215, 2011.

A. August and B. Dupont, CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase, International Immunology, vol.6, issue.5, pp.769-74, 1994.
DOI : 10.1093/intimm/6.5.769

F. Pages, M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes et al., Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling, Nature, vol.369, issue.6478, pp.327-336, 1994.
DOI : 10.1038/369327a0

K. Prasad, Y. Cai, M. Raab, B. Duckworth, L. Cantley et al., T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif., Proceedings of the National Academy of Sciences, vol.91, issue.7, pp.2834-2842, 1994.
DOI : 10.1073/pnas.91.7.2834

A. Ghigo and E. Hirsch, Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential, Recent Patents on Inflammation & Allergy Drug Discovery, vol.2, issue.1, pp.1-10, 2008.
DOI : 10.2174/187221308783399270

O. 'brien, K. Gran, B. Rostami, and A. , T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis, Immunology, vol.2, pp.99-115, 2010.

M. Hayden, A. West, and S. Ghosh, NF-??B and the immune response, Oncogene, vol.159, issue.51, pp.6758-80, 2006.
DOI : 10.1038/nature02273

B. Lund, N. Ashikian, H. Ta, Y. Chakryan, K. Manoukian et al., Increased CXCL8 (IL-8) expression in Multiple Sclerosis, Journal of Neuroimmunology, vol.155, issue.1-2, pp.161-71, 2004.
DOI : 10.1016/j.jneuroim.2004.06.008

C. Malmestrom, B. Andersson, S. Haghighi, and L. J. , IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles, Journal of Neuroimmunology, vol.175, issue.1-2, pp.176-82, 2006.
DOI : 10.1016/j.jneuroim.2006.03.004

S. Serada, M. Fujimoto, M. Mihara, N. Koike, Y. Ohsugi et al., IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences, vol.105, issue.26, pp.9041-9047, 2008.
DOI : 10.1073/pnas.0802218105

V. Brucklacher-waldert, K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa, Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis, Brain, vol.132, issue.12, pp.3329-3370, 2009.
DOI : 10.1093/brain/awp289

H. Park, Z. Li, X. Yang, S. Chang, R. Nurieva et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nature Immunology, vol.103, issue.11, pp.1133-1174, 2005.
DOI : 10.1038/35051100

F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani, Defining the human T helper 17 cell phenotype, Trends in Immunology, vol.33, issue.10, pp.505-517, 2012.
DOI : 10.1016/j.it.2012.05.004

M. Pelletier, L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia et al., Evidence for a cross-talk between human neutrophils and Th17 cells, Blood, vol.115, issue.2, pp.335-378, 2010.
DOI : 10.1182/blood-2009-04-216085

J. Huppert, D. Closhen, A. Croxford, R. White, P. Kulig et al., Cellular mechanisms of IL-17-induced blood-brain barrier disruption, The FASEB Journal, vol.24, issue.4, pp.1023-1057, 2010.
DOI : 10.1096/fj.09-141978

J. Tzartos, M. Friese, M. Craner, J. Palace, J. Newcombe et al., Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis, The American Journal of Pathology, vol.172, issue.1, pp.146-55, 2008.
DOI : 10.2353/ajpath.2008.070690

C. Hedegaard, M. Krakauer, K. Bendtzen, H. Lund, F. Sellebjerg et al., T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis, Immunology, vol.33, issue.Suppl. 3, pp.161-170, 2008.
DOI : 10.1111/j.1365-2567.2008.02837.x

V. Santarlasci, L. Maggi, M. Capone, V. Querci, L. Beltrame et al., Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion, Immunity, vol.36, issue.2, pp.201-215, 2012.
DOI : 10.1016/j.immuni.2011.12.013

J. Hong, H. Li, M. Chen, Y. Zang, S. Skinner et al., Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis, International Immunology, vol.21, issue.12, pp.1329-1369, 2009.
DOI : 10.1093/intimm/dxp100

J. Tzartos, M. Craner, M. Friese, K. Jakobsen, J. Newcombe et al., IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain, The American Journal of Pathology, vol.178, issue.2, pp.794-802, 2011.
DOI : 10.1016/j.ajpath.2010.10.043

J. Fontenot and A. Rudensky, A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3, Nature Immunology, vol.14, issue.4, pp.331-338, 2005.
DOI : 10.1093/intimm/dxh165

S. Ziegler, FOXP3: Of Mice and Men, Annual Review of Immunology, vol.24, issue.1, pp.209-235, 2006.
DOI : 10.1146/annurev.immunol.24.021605.090547

A. Zozulya and H. Wiendl, The role of regulatory T cells in multiple sclerosis, Nature Clinical Practice Neurology, vol.180, issue.7, pp.384-98, 2008.
DOI : 10.1038/ncpneuro0832

D. Libera, D. , D. Mitri, D. Bergami, A. Centonze et al., T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients, PLoS ONE, vol.118, issue.1???2, p.21386, 2011.
DOI : 10.1371/journal.pone.0021386.g004

C. Camperio, S. Caristi, G. Fanelli, M. Soligo, D. Porto et al., Forkhead Transcription Factor FOXP3 Upregulates CD25 Expression through Cooperation with RelA/NF-??B, PLoS ONE, vol.185, issue.10, p.48303, 2012.
DOI : 10.1371/journal.pone.0048303.s003

C. Scotta, M. Soligo, C. Camperio, and E. Piccolella, FOXP3 Induced by CD28/B7 Interaction Regulates CD25 and Anergic Phenotype in Human CD4+CD25- T Lymphocytes, The Journal of Immunology, vol.181, issue.2, pp.1025-1058, 2008.
DOI : 10.4049/jimmunol.181.2.1025

C. Lin and T. Hunig, Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist, European Journal of Immunology, vol.33, issue.3, pp.626-664, 2003.
DOI : 10.1002/eji.200323570

Z. Waibler, L. Sender, C. Merten, R. Hartig, S. Kliche et al., Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies, PLoS ONE, vol.193, issue.3, p.1708, 2008.
DOI : 10.1371/journal.pone.0001708.s005

G. Suntharalingam, M. Perry, S. Ward, S. Brett, A. Castello-cortes et al., Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412, New England Journal of Medicine, vol.355, issue.10, pp.1018-1046, 2006.
DOI : 10.1056/NEJMoa063842

M. Muscolini, C. Camperio, C. Capuano, S. Caristi, E. Piccolella et al., Phosphatidylinositol 4-Phosphate 5-Kinase ?? Activation Critically Contributes to CD28-Dependent Signaling Responses, The Journal of Immunology, vol.190, issue.10, pp.5279-86, 2013.
DOI : 10.4049/jimmunol.1203157

URL : https://hal.archives-ouvertes.fr/pasteur-01054187

F. Garcon, D. Patton, J. Emery, E. Hirsch, R. Rottapel et al., CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer, Blood, vol.111, issue.3, pp.1464-71, 2008.
DOI : 10.1182/blood-2007-08-108050

K. Okkenhaug, D. Patton, A. Bilancio, F. Garcon, W. Rowan et al., The p110?? Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells, The Journal of Immunology, vol.177, issue.8, pp.5122-5130, 2006.
DOI : 10.4049/jimmunol.177.8.5122

S. Sauer, L. Bruno, A. Hertweck, D. Finlay, M. Leleu et al., T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR, Proceedings of the National Academy of Sciences, vol.105, issue.22, pp.7797-802, 2008.
DOI : 10.1073/pnas.0800928105

L. Sinclair, D. Finlay, C. Feijoo, G. Cornish, A. Gray et al., Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking, Nature Immunology, vol.180, issue.5, pp.513-534, 2008.
DOI : 10.1016/S0003-2697(02)00607-3

A. Ghigo, F. Damilano, L. Braccini, and E. Hirsch, PI3K inhibition in inflammation: Toward tailored therapies for specific diseases, BioEssays, vol.104, issue.3, pp.185-96, 2010.
DOI : 10.1002/bies.200900150

S. Maira, S. Pecchi, A. Huang, M. Burger, M. Knapp et al., Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor, Molecular Cancer Therapeutics, vol.11, issue.2, pp.317-345, 2012.
DOI : 10.1158/1535-7163.MCT-11-0474

C. Gasperini and S. Ruggieri, Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach, Drug Design, Development and Therapy, vol.6, pp.175-86, 2012.
DOI : 10.2147/DDDT.S8927

J. Goverman, Autoimmune T cell responses in the central nervous system, Nature Reviews Immunology, vol.30, issue.6, pp.393-407, 2009.
DOI : 10.1038/nri2550